Article Text
Abstract
Glucocorticoids are commonly used for neurological disorders, but they can have significant adverse effects, including adrenal insufficiency, hyperglycaemia, osteoporosis and increased infection risk. Long-term use of corticosteroids requires the prescriber to plan risk mitigation, including monitoring and often coprescribing. This article highlights the potential risks of corticosteroid prescribing and draws together up-to-date guidance with multispecialty input to clarify ways of reducing those risks. We discuss home blood glucose monitoring and consider a steroid safety checklist to promote safer steroid prescribing.
- CLINICAL NEUROLOGY
- STEROIDS
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Contributors APJ manuscript writing and literature review. MD and JW editing of manuscript. LH and CS editing of manuscript and development of ‘grab bags’. FMM concept, steroid safety checklist and editing of manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed by Aisling Carr, London, UK.
Read the full text or download the PDF:
Other content recommended for you
- Takotsubo cardiomyopathy associated with adrenal insufficiency in the context of long-term steroid use mimicking acute coronary syndrome
- Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
- Glucocorticoid induced adrenal insufficiency
- Advances in the management of diabetes: new devices for type 1 diabetes
- Systemic corticosteroid therapy—side effects and their management
- Use of Quick Response (QR) coded bracelets and cards for the improvement of cortisol deficiency/Addison’s disease management: an audit of quality of care of the management of steroid deficiency in acute illness
- Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial
- Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden
- Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
- Bilateral osteonecrosis of the hip in panhypopituitarism